The number of people with susceptibility test result for rifampicin in Greece
Greece: The number of people with susceptibility test result for rifampicin was 55 in 2021. ▼ Falling
Latest (2021)
55
Change on year
down 79.1%
World rank
121st
of 155 countries
All-time high
263
in 2020
All-time low
55
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Greece, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Greece stood at 55. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 79.1% on the previous year and down 64.1% over five years.
Greece ranks 121st of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Greece, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 153 | — |
| 2018 | 120 | -21.6% |
| 2019 | 175 | +45.8% |
| 2020 | 263 | +50.3% |
| 2021 | 55 | -79.1% |
Greece compared with similar countries
- Greece's 55 is below the median for high income countries, which is 142, 39% of the median. (61 countries reporting)
- Greece's 55 is below the median for Europe & Central Asia, which is 229.5, 24% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 149.33 | 120 | 175 | 3 |
| 2020s | 159 | 55 | 263 | 2 |
Countries ranked near Greece
- 119 Slovenia 58 compare
- 120 Trinidad and Tobago 57 compare
- 121 Montenegro 55 compare
- 123 Maldives 46 compare
- 124 Jamaica 44 compare
More health data for Greece
- Un projection of annual infant deaths, annual growth rate -4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0227 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,321 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.24 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0175 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.88 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Greece?
- The number of people with susceptibility test result for rifampicin in Greece was 55 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Greece?
- The highest recorded value was 263 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Greece?
- The lowest recorded value was 55 in 2021.
- How does Greece rank for the number of people with susceptibility test result for rifampicin?
- Greece ranks 121st out of 155 countries with data for 2021.
- Where does this Greece data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).